A phase II trial of riluzole, an antagonist of metabotropic...

  • Main
  • 2018 / 02
  • A phase II trial of riluzole, an antagonist of metabotropic...
Pigment Cell & Melanoma Research 2018 / 02

A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma

Mehnert, Janice M., Silk, Ann W., Wen, Yu, Lee, J. H., Dudek, Liesel, Jeong, Byeong-Seon, Li, Jiadong, Schenkel, Jason M., Sadimin, Evita, Kane, Michael, Lin, Hongxia, Shih, Weichung J., Zloza, Andrew
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Pigment Cell & Melanoma Research
DOI:
10.1111/pcmr.12694
Date:
February, 2018
File:
PDF, 906 KB
english, 2018
Conversion to is in progress
Conversion to is failed